Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their partnership to speed up the development and deployment of healthcare AI tools. GE Healthcare teamed up with AWS to build generative AI for medical use in 2024.
Now, a Thailand-based healthcare startup, HD, has built a marketplace, HDmall, to digitize the fragmented medical industry in Southeast Asia. The startup helps users find healthcare providers like hospitals and clinics. It also assists people in finding specific surgeries and health check-ups, aggregates services to lower costs and provides users with installment payment options.
The startup has secured $7.8 million in equity funding to enhance its marketplace and invest further in its AI technology. The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a healthtech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S. and Canada, and it launched an accelerator called IDEA Studios last June.) Other participants in HD’s funding included SBI Ven Capital, M Venture Partners, FEBE Venture, and Partech Partners also participated in the latest financing.
“MSD, which produces the HPV vaccines, reached out to [us] because we were already selling a lot of HPV vaccines online that were being administered at the hospitals and clinics we work with,” co-founder and CEO of HD Sheji Ho said in an exclusive interview with TechCrunch. “And if you look at the numbers, we [offer] the largest number for vaccines online in the markets.”
The five-year-old startup’s marketplace has over 30,000 stock-keeping units (SKUs) from more than 2,500 hospitals and clinics and a handful of pharmaceutical partners and 400,000 paying customers across Thailand and Indonesia, generating $100 million in annual gross transaction volume, Ho noted. It aims to reach 5,000 healthcare providers and 600,000 patients in 2025.
Source- Techcrunch
#Merck #Healthcare #Marketplace #Pharma #SoutheastAsia #HealthcareInnovation #DigitalHealth #MedTech #PharmaTech #HealthTech
Now, a Thailand-based healthcare startup, HD, has built a marketplace, HDmall, to digitize the fragmented medical industry in Southeast Asia. The startup helps users find healthcare providers like hospitals and clinics. It also assists people in finding specific surgeries and health check-ups, aggregates services to lower costs and provides users with installment payment options.
The startup has secured $7.8 million in equity funding to enhance its marketplace and invest further in its AI technology. The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a healthtech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S. and Canada, and it launched an accelerator called IDEA Studios last June.) Other participants in HD’s funding included SBI Ven Capital, M Venture Partners, FEBE Venture, and Partech Partners also participated in the latest financing.
“MSD, which produces the HPV vaccines, reached out to [us] because we were already selling a lot of HPV vaccines online that were being administered at the hospitals and clinics we work with,” co-founder and CEO of HD Sheji Ho said in an exclusive interview with TechCrunch. “And if you look at the numbers, we [offer] the largest number for vaccines online in the markets.”
The five-year-old startup’s marketplace has over 30,000 stock-keeping units (SKUs) from more than 2,500 hospitals and clinics and a handful of pharmaceutical partners and 400,000 paying customers across Thailand and Indonesia, generating $100 million in annual gross transaction volume, Ho noted. It aims to reach 5,000 healthcare providers and 600,000 patients in 2025.
Source- Techcrunch
#Merck #Healthcare #Marketplace #Pharma #SoutheastAsia #HealthcareInnovation #DigitalHealth #MedTech #PharmaTech #HealthTech
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their partnership to speed up the development and deployment of healthcare AI tools. GE Healthcare teamed up with AWS to build generative AI for medical use in 2024.
Now, a Thailand-based healthcare startup, HD, has built a marketplace, HDmall, to digitize the fragmented medical industry in Southeast Asia. The startup helps users find healthcare providers like hospitals and clinics. It also assists people in finding specific surgeries and health check-ups, aggregates services to lower costs and provides users with installment payment options.
The startup has secured $7.8 million in equity funding to enhance its marketplace and invest further in its AI technology. The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a healthtech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S. and Canada, and it launched an accelerator called IDEA Studios last June.) Other participants in HD’s funding included SBI Ven Capital, M Venture Partners, FEBE Venture, and Partech Partners also participated in the latest financing.
“MSD, which produces the HPV vaccines, reached out to [us] because we were already selling a lot of HPV vaccines online that were being administered at the hospitals and clinics we work with,” co-founder and CEO of HD Sheji Ho said in an exclusive interview with TechCrunch. “And if you look at the numbers, we [offer] the largest number for vaccines online in the markets.”
The five-year-old startup’s marketplace has over 30,000 stock-keeping units (SKUs) from more than 2,500 hospitals and clinics and a handful of pharmaceutical partners and 400,000 paying customers across Thailand and Indonesia, generating $100 million in annual gross transaction volume, Ho noted. It aims to reach 5,000 healthcare providers and 600,000 patients in 2025.
Source- Techcrunch
#Merck #Healthcare #Marketplace #Pharma #SoutheastAsia #HealthcareInnovation #DigitalHealth #MedTech #PharmaTech #HealthTech
